Elsevier

Vascular Pharmacology

Volume 52, Issues 3–4, March–April 2010, Pages 166-170
Vascular Pharmacology

Review
The crosstalk between thyroid hormones and the Renin–Angiotensin System

https://doi.org/10.1016/j.vph.2009.10.009Get rights and content
Under an Elsevier user license
open access

Abstract

Thyroid hormones (THs) exert multiple effects on the heart and vascular system. As a consequence, altered cardiovascular function observed in the thyroid diseases corresponds to one of the most important and clinically relevant aspects found in both hyperthyroidism and hypothyroidism. Besides THs' direct effects on the heart and vascular system, in the last three decades several studies have implicated the Renin–Angiotensin System (RAS) in some of the cardiovascular effects of THs, with this interaction suggesting that RAS may be an important mediator of THs actions. In the present review, we discuss the alterations in the circulating RAS, as well as modifications in cardiac and vascular RAS which are involved in the cardiovascular alterations found during the modulation of TH levels. In addition, considering the important role that both systems present during fetal and neonatal periods, we also review the interaction between THs and the RAS in the development of cardiovascular system. A greater understanding of the role of the RAS in hyperthyroidism and hypothyroidism, during early or adult life will presumably facilitate the evolution of newer, targeted therapies.

Keywords

Thyroid hormones
Renin–Angiotensin System
Cardiac hypertrophy
Vasodilatation

Cited by (0)